Comment on CMS-2026-1255-0001
Oncology Nursing SocietySupportAdvocacy
Summary: The Oncology Nursing Society (ONS), representing over 100,000 oncology nurses, supports the proposed rule to modernize prior authorization processes, expand interoperability, and increase transparency for cancer drugs. They advocate for specific improvements, including a 24-hour decision timeframe for cancer drugs, the retention of formulary information in APIs, and streamlined requirements for laboratory tests and DMEPOS items.
See attached